84 related articles for article (PubMed ID: 22093171)
1. Late presentation for HIV diagnosis and care in Germany.
Zoufaly A; an der Heiden M; Marcus U; Hoffmann C; Stellbrink H; Voss L; van Lunzen J; Hamouda O;
HIV Med; 2012 Mar; 13(3):172-81. PubMed ID: 22093171
[TBL] [Abstract][Full Text] [Related]
2. Late presentations and missed opportunities among newly diagnosed HIV patients presenting to a specialty clinic in Lebanon.
Mahmoud M; Ballouz T; Lahoud C; Adnan J; Habib PA; Saab R; Farhat H; Hussein ME; Rizk N
Sci Rep; 2024 Apr; 14(1):8296. PubMed ID: 38594292
[TBL] [Abstract][Full Text] [Related]
3. Decrease in late presentation for HIV care in Kinshasa, DRC, 2006-2020.
Ngongo NM; Nani-Tuma HS; Mambimbi MM; Mashi ML; Izizag BB; Ndolumingu FK; Maes N; Moutschen M; Darcis G
AIDS Res Ther; 2021 Jul; 18(1):41. PubMed ID: 34271957
[TBL] [Abstract][Full Text] [Related]
4. Determinants of late presentation of HIV positive individuals: a study in Kosovo.
Tolaj I; Mehmeti M; Gashi H; Kasumi A
HIV Res Clin Pract; 2024 Dec; 25(1):2298093. PubMed ID: 38149661
[TBL] [Abstract][Full Text] [Related]
5. Patient characteristics and determinants of CD4 at diagnosis of HIV in Mexico from 2008 to 2017: a 10-year population-based study.
Azamar-Alonso A; Bautista-Arredondo SA; Smaill F; Mbuagbaw L; Costa AP; Tarride JE
AIDS Res Ther; 2021 Nov; 18(1):84. PubMed ID: 34774077
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Late HIV Presentation in Patients Treated at a Single Belgian Reference Centre from 2018 to 2022.
Scaia D; Fombellida K; Maes N; El Moussaoui M; Darcis G
Infect Dis Rep; 2024 Mar; 16(2):239-248. PubMed ID: 38525766
[TBL] [Abstract][Full Text] [Related]
7. Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat All.
Ford N; Vitoria M; Doherty M
J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29436776
[No Abstract] [Full Text] [Related]
8. Late Presentation of HIV Infection in the Netherlands: Reasons for Late Diagnoses and Impact on Vocational Functioning.
van Opstal SEM; van der Zwan JS; Wagener MN; Been SK; Miedema HS; Roelofs PDDM; van Gorp ECM
AIDS Behav; 2018 Aug; 22(8):2593-2603. PubMed ID: 29550940
[TBL] [Abstract][Full Text] [Related]
9. Late presenters among persons with a new HIV diagnosis in Italy, 2010-2011.
Camoni L; Raimondo M; Regine V; Salfa MC; Suligoi B;
BMC Public Health; 2013 Mar; 13():281. PubMed ID: 23537210
[TBL] [Abstract][Full Text] [Related]
10. Analysing Early Diagnosis Strategies for HIV Infection: A Retrospective Study of Missed Diagnostic Opportunities.
Giménez-Arufe V; Rotea-Salvo S; Martínez-Pradeda A; Mena-de-Cea Á; Margusino-Framiñán L; Suanzes-Hernández J; Martín Herranz MI; Cid-Silva P
Healthcare (Basel); 2024 Jan; 12(3):. PubMed ID: 38338246
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with late initiation of antiretroviral therapy in Iran's HIV/AIDS surveillance data.
Sharafi M; Mirahmadizadeh A; Hassanzadeh J; Seif M; Heiran A
Sci Rep; 2024 Jan; 14(1):199. PubMed ID: 38167855
[TBL] [Abstract][Full Text] [Related]
12. Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study.
Valbert F; Koppe U; Schmidt D; Krings A; Gunsenheimer-Bartmeyer B; Dröge P; Ruhnke T; Behrens G; Bickel M; Boesecke C; Esser S; Wasem J; Neumann A
Arch Public Health; 2023 Aug; 81(1):159. PubMed ID: 37626414
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, characteristics and challenges of late HIV diagnosis in Germany: an expert narrative review.
Boesecke C; Schellberg S; Schneider J; Schuettfort G; Stocker H
Infection; 2023 Oct; 51(5):1223-1239. PubMed ID: 37470977
[TBL] [Abstract][Full Text] [Related]
14. Association of demographics, HCV co-infection, HIV-1 subtypes and genetic clustering with late HIV diagnosis: a retrospective analysis from the Japanese Drug Resistance HIV-1 Surveillance Network.
Otani M; Shiino T; Hachiya A; Gatanaga H; Watanabe D; Minami R; Nishizawa M; Teshima T; Yoshida S; Ito T; Hayashida T; Koga M; Nagashima M; Sadamasu K; Kondo M; Kato S; Uno S; Taniguchi T; Igari H; Samukawa S; Nakajima H; Yoshino Y; Horiba M; Moro H; Watanabe T; Imahashi M; Yokomaku Y; Mori H; Fujii T; Takada K; Nakamura A; Nakamura H; Tateyama M; Matsushita S; Yoshimura K; Sugiura W; Matano T; Kikuchi T;
J Int AIDS Soc; 2023 May; 26(5):e26086. PubMed ID: 37221951
[TBL] [Abstract][Full Text] [Related]
15. Impact of COVID-19 on HIV late diagnosis in a specialized German centre.
van Bremen K; Monin M; Schlabe S; Bischoff J; Rieke GJ; Schwarze-Zander C; Wasmuth JC; Rockstroh JK; Boesecke C
HIV Med; 2022 Dec; 23(11):1209-1213. PubMed ID: 36263724
[TBL] [Abstract][Full Text] [Related]
16. Estimation of the determinants for HIV late presentation using the traditional definition and molecular clock-inferred dates: Evidence that older age, heterosexual risk group and more recent diagnosis are prognostic factors.
Kostaki EG; Limnaios S; Adamis G; Xylomenos G; Chini M; Mangafas N; Lazanas M; Patrinos S; Metallidis S; Tsachouridou O; Papastamopoulos V; Chatzidimitriou D; Antoniadou A; Papadopoulos A; Protopapas K; Tsiara C; Psichogiou M; Basoulis D; Pilalas D; Paraskeva D; Chrysos G; Paparizos V; Kourkounti S; Sambatakou H; Bolanos V; Sipsas NV; Lada M; Barbounakis E; Kantzilaki E; Panagopoulos P; Petrakis V; Drimis S; Katsarolis I; Lagiou P; Hatzakis A; Magiorkinis G; Skoura L; Paraskevis D
HIV Med; 2022 Dec; 23(11):1143-1152. PubMed ID: 36258653
[TBL] [Abstract][Full Text] [Related]
17. The impact of regional socioeconomic deprivation on the timing of HIV diagnosis: a cross-sectional study in Germany.
Pantke A; Hoebel J; An der Heiden M; Michalski N; Gunsenheimer-Bartmeyer B; Hanke K; Bannert N; Bremer V; Koppe U
BMC Infect Dis; 2022 Mar; 22(1):258. PubMed ID: 35296239
[TBL] [Abstract][Full Text] [Related]
18. Late presentation for HIV remains a major health issue in Spain: Results from a multicenter cohort study, 2004-2018.
Rava M; Domínguez-Domínguez L; Bisbal O; López-Cortés LF; Busca C; Antela A; González-Ruano P; Hernández C; Iribarren JA; Rubio R; Moreno S; Jarrín I;
PLoS One; 2021; 16(4):e0249864. PubMed ID: 33882093
[TBL] [Abstract][Full Text] [Related]
19. Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study).
Schäfer G; Hoffmann C; Arasteh K; Schürmann D; Stephan C; Jensen B; Stoll M; Bogner JR; Faetkenheuer G; Rockstroh J; Klinker H; Härter G; Stöhr A; Degen O; Freiwald E; Hüfner A; Jordan S; Schulze Zur Wiesch J; Addo M; Lohse AW; van Lunzen J; Schmiedel S;
AIDS Res Ther; 2019 Nov; 16(1):34. PubMed ID: 31729999
[TBL] [Abstract][Full Text] [Related]
20. Low variation in initial CD4 cell count in a HIV referral center, in Salvador, Brazil, from 2002 to 2015.
Pereira MF; Luz E; Netto EM; Barbosa MHF; Brites C
Braz J Infect Dis; 2018; 22(3):245-247. PubMed ID: 29883585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
